Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 81
Filter
Add more filters










Publication year range
1.
Sci Rep ; 11(1): 1347, 2021 01 14.
Article in English | MEDLINE | ID: mdl-33446747

ABSTRACT

Iron deficiency anemia (IDA) is a common micronutrient deficiency among pregnant women with severe consequences including impaired immuno-inflammatory system, premature birth, fetal death etc. The present study aimed to investigate the effects of three iron supplements on IDA female rats and their offspring. The IDA female rat model was established with low iron diet and the rats were then mated. After pregnancy, rats were fed diets containing different iron supplements (iron polysaccharide complex, iron protein succinylate and ferrous sulfate) until their offspring were 42 days old. Pregnancy outcomes, haematological, iron metabolism, physical and neurological development indexes were determined. The results showed that all three iron supplements improved the levels of hematological parameters of both mother and offspring rats. After iron supplementation, serum iron, transferrin saturation and serum ferritin levels were increased compared with the IDA group. The level of ferritin light chain in the liver and spleen of both mother and offspring rats in iron supplemented groups was significantly higher than that of the IDA group. The average number of born alive per litter in the iron treatment groups was significantly higher than that in the IDA group. Iron supplements also improved the physical growth and neurobehavioral development of offspring rats. It was also found that iron supplementation improved the expression of ferritin light chain and the synaptic growth associated proteins in the brain and hippocampus. No significant difference was found in the efficacy of three iron supplements. These results suggest that pregnant and postpartum IDA affects pregnancy outcomes, offspring physical development and causes neural impairment. Sufficient iron supplementation can significantly improve IDA and its adverse effects on both mother and offspring.


Subject(s)
Anemia, Iron-Deficiency , Ferrous Compounds/pharmacology , Metalloproteins/pharmacology , Pregnancy Complications, Hematologic , Pregnancy Outcome , Succinates/pharmacology , Anemia, Iron-Deficiency/blood , Anemia, Iron-Deficiency/drug therapy , Animals , Female , Iron/pharmacology , Pregnancy , Pregnancy Complications, Hematologic/blood , Pregnancy Complications, Hematologic/drug therapy , Rats , Rats, Wistar
2.
J Nanobiotechnology ; 18(1): 48, 2020 Mar 17.
Article in English | MEDLINE | ID: mdl-32183823

ABSTRACT

BACKGROUND: Specific targeting ability and good cell penetration are two critical requirements of tumor-targeted delivery systems. In the present work, we developed a novel matrix metalloprotein-triggered, cell-penetrating, peptide-modified, star-shaped nanoparticle (NP) based on a functionalized copolymer (MePEG-Peptide-Tri-CL), with the peptide composed of GPLGIAG (matrix metalloprotein-triggered peptide for targeted delivery) and r9 (cell-penetrating peptide for penetration improvement) to enhance its biological specificity and therapeutic effect. RESULTS: Based on the in vitro release study, a sustained release profile was achieved for curcumin (Cur) release from the Cur-P-NPs at pH 7.4. Furthermore, the release rate of Cur was accelerated in the enzymatic reaction. MTT assay results indicated that the biocompatibility of polymer NPs (P-NPs) was inversely related to the NP concentration, while the efficiency toward tumor cell inhibition was positively related to the Cur-P-NP concentration. In addition, Cur-P-NPs showed higher fluorescence intensity than Cur-NPs in tumor cells, indicating improved penetration of tumor cells. An in vivo biodistribution study further demonstrated that Cur-P-NPs exhibited stronger targeting to A549 xenografts than to normal tissue. Furthermore, the strongest tumor growth inhibition (76.95%) was observed in Cur-P-NP-treated A549 tumor xenograft nude mice, with slight pulmonary toxicity. CONCLUSION: All results demonstrated that Cur-P-NP is a promising drug delivery system that possesses specific enzyme responsiveness for use in anti-tumor therapy.


Subject(s)
Cell-Penetrating Peptides/pharmacology , Drug Delivery Systems/methods , Metalloproteins/pharmacology , Nanoparticles/administration & dosage , Animals , Cell Line, Tumor , Cell-Penetrating Peptides/chemistry , Curcumin/pharmacology , Drug Carriers , Drug Liberation , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Nanoparticles/chemistry , Particle Size , Polymers/chemistry , Tissue Distribution , Xenograft Model Antitumor Assays
3.
ACS Infect Dis ; 5(10): 1693-1697, 2019 10 11.
Article in English | MEDLINE | ID: mdl-31475514

ABSTRACT

Gallium nitrate (Ganite) is a potential drug for the treatment of Pseudomonas aeruginosa infection. CRISPR/Cas9-based gene mutagenesis studies reveal that siderophore pyochelin-facilitated uptake and an ABC transporter are two major Ga3+ internalization pathways in Pseudomonas aeruginosa (P. aeruginosa). Crystal structures reveal that Ga3+ and Fe3+ occupy exactly the same metal site of HitA, a periplasmic iron-binding protein of the ABC transporter system. The study provides a molecular basis for Ga3+ internalization by P. aeruginosa and facilitates gallium-based antimicrobial drug development.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/metabolism , Gallium/metabolism , Metalloproteins/chemistry , Metalloproteins/metabolism , Pseudomonas aeruginosa/metabolism , ATP-Binding Cassette Transporters , Anti-Bacterial Agents/pharmacology , Drug Development , Iron/metabolism , Metalloproteins/pharmacology , Models, Molecular , Mutagenesis , Periplasm/metabolism , Protein Conformation , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/drug effects , Siderophores/genetics , Siderophores/metabolism
4.
Angew Chem Int Ed Engl ; 57(1): 287-291, 2018 01 02.
Article in English | MEDLINE | ID: mdl-29144008

ABSTRACT

The breast cancer stem cell (CSC) and bulk breast cancer cell potency of a series of metallopeptides containing dichloro(1,10-phenanthroline)copper(II) and various organelle-targeting peptide sequences is reported. The mitochondria-targeting metallopeptide 1 exploits the higher mitochondrial load in breast CSCs over the corresponding non-CSCs and the vulnerability of breast CSCs to mitochondrial damage to potently and selectively kill breast CSCs. Strikingly, 1 reduces the formation and size of mammospheres to a greater extent than salinomycin, an established CSC-potent agent. Mechanistic studies show that 1 enters CSC mitochondria, induces mitochondrial dysfunction, generates reactive oxygen species (ROS), activates JNK and p38 pathways, and prompts apoptosis. To the best of our knowledge, 1 is the first metallopeptide to selectivity kill breast CSCs in vitro.


Subject(s)
Breast Neoplasms/pathology , Coordination Complexes/pharmacology , Metalloproteins/pharmacology , Mitochondria/drug effects , Neoplastic Stem Cells/pathology , Peptides/pharmacology , Phenanthrolines/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Chromatography, High Pressure Liquid , Female , Humans , Inhibitory Concentration 50 , MAP Kinase Kinase 4/metabolism , Metalloproteins/chemistry , Pyrans/pharmacology , Reactive Oxygen Species/metabolism , Spectrometry, Mass, Electrospray Ionization , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , p38 Mitogen-Activated Protein Kinases/metabolism
5.
J Enzyme Inhib Med Chem ; 31(6): 1502-11, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27033431

ABSTRACT

Xylarinase is a bi-functional fibrinolytic metalloprotease isolated from the culture filtrate of endophytic fungus Xylaria curta which is monomeric with a molecular mass of ∼33.76 kDa. The enzyme displayed both plasmin and tissue plasminogen activator like activity under in vitro conditions. It hydrolyses Aα and Bß chains of the fibrinogen. Optimal fibrinolytic activity of xylarinase is observed at 35 °C, pH 8. Ca(2+) stimulated the fibrinolytic activity of xylarinase while Fe(2+) and Zn(2+) inhibited suggesting it to be a metalloprotease. The Km and Vmax values of xylarinase were 240.9 µM and 1.10 U/ml for fibrinogen and 246 µM and 1.22 U/ml for fibrin, respectively. Xylarinase was found to prolong the activated partial thromboplastin time and prothrombin time. The N-terminal sequence of xylarinase (SNGPLPGGVVWAG) did not show any homology with previously known fibrinolytic enzymes. Thus xylarinase is a novel fibrinolytic metalloprotease which could be possibly used as a new clot busting enzyme.


Subject(s)
Antithrombins/pharmacology , Fungal Proteins/pharmacology , Metalloproteins/pharmacology , Xylariales/enzymology , Amino Acid Sequence , Electrophoresis, Polyacrylamide Gel , Fibrinolysis/drug effects , Fungal Proteins/chemistry , Kinetics , Metalloproteins/chemistry , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
6.
Toxicon ; 110: 90-109, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26690979

ABSTRACT

Ureases are metalloenzymes that hydrolyze urea into ammonia and carbon dioxide. They were the first enzymes to be crystallized and, with them, the notion that enzymes are proteins became accepted. Novel toxic properties of ureases that are independent of their enzyme activity have been discovered in the last three decades. Since our first description of the neurotoxic properties of canatoxin, an isoform of the jack bean urease, which appeared in Toxicon in 1981, about one hundred articles have been published on "new" properties of plant and microbial ureases. Here we review the present knowledge on the non-enzymatic properties of ureases. Plant ureases and microbial ureases are fungitoxic to filamentous fungi and yeasts by a mechanism involving fungal membrane permeabilization. Plant and at least some bacterial ureases have potent insecticidal effects. This entomotoxicity relies partly on an internal peptide released upon proteolysis of ingested urease by insect digestive enzymes. The intact protein and its derived peptide(s) are neurotoxic to insects and affect a number of other physiological functions, such as diuresis, muscle contraction and immunity. In mammal models some ureases are acutely neurotoxic upon injection, at least partially by enzyme-independent effects. For a long time bacterial ureases have been recognized as important virulence factors of diseases by urease-producing microorganisms. Ureases activate exocytosis in different mammalian cells recruiting eicosanoids and Ca(2+)-dependent pathways, even when their ureolytic activity is blocked by an irreversible inhibitor. Ureases are chemotactic factors recognized by neutrophils (and some bacteria), activating them and also platelets into a pro-inflammatory "status". Secretion-induction by ureases may play a role in fungal and bacterial diseases in humans and other animals. The now recognized "moonlighting" properties of these proteins have renewed interest in ureases for their biotechnological potential to improve plant defense against pests and as potential targets to ameliorate diseases due to pathogenic urease-producing microorganisms.


Subject(s)
Metalloproteins/toxicity , Neurotoxins/toxicity , Urease/toxicity , Animals , Apoenzymes/genetics , Apoenzymes/metabolism , Apoenzymes/pharmacology , Apoenzymes/toxicity , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Bacterial Proteins/pharmacology , Bacterial Proteins/toxicity , Fungicides, Industrial/pharmacology , Fungicides, Industrial/toxicity , Humans , Insecticides/metabolism , Insecticides/pharmacology , Insecticides/toxicity , Isoenzymes/genetics , Isoenzymes/metabolism , Isoenzymes/pharmacology , Isoenzymes/toxicity , Metalloproteins/genetics , Metalloproteins/metabolism , Metalloproteins/pharmacology , Neurotoxins/genetics , Neurotoxins/metabolism , Neurotoxins/pharmacology , Plant Proteins/genetics , Plant Proteins/metabolism , Plant Proteins/pharmacology , Plant Proteins/toxicity , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , Recombinant Proteins/toxicity , Urease/genetics , Urease/metabolism , Urease/pharmacology
7.
Free Radic Res ; 49(10): 1259-1268, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26110460

ABSTRACT

BACKGROUND: The objective of the present study was to determine whether single administration of the antioxidant enzyme bovine superoxide dismutase (bSOD) after radiation therapy (RT) mitigates development of pulmonary toxicity in rats. METHODS: Female F344 rats (n = 60) were divided among six experimental groups: (1) RT, single dose of 21 Gy to the right hemithorax; (2) RT + 5 mg/kg bSOD; (3) RT + 15 mg/kg bSOD; (4) No RT; (5) sham RT + 5 mg/kg bSOD; and (6) sham RT + 15 mg/kg bSOD. A single subcutaneous injection of bSOD (5 or 15 mg/kg) was administered 24 h post-radiation. The effects of bSOD on radiation-induced lung injury were assessed by measurement of body weight, breathing frequency, and histopathological changes. Immunohistochemistry was used to evaluate oxidative stress (8-OHdG(+), NOX4(+), nitrotyrosine(+), and 4HNE(+) cells), macrophage activation (ED1(+)), and expression of profibrotic transforming growth factor-ß or TGF-ß in irradiated tissue. RESULTS: Radiation led to an increase in all the evaluated parameters. Treatment with 15 mg/kg bSOD significantly decreased levels of all the evaluated parameters including tissue damage and breathing frequency starting 6 weeks post-radiation. Animals treated with 5 mg/kg bSOD trended toward a suppression of radiation-induced lung damage but did not reach statistical significance. CONCLUSIONS: The single application of bSOD (15 mg/kg) ameliorates radiation-induced lung injury through suppression of reactive oxygen species/reactive nitrogen species or ROS/RNS-dependent tissue damage.


Subject(s)
Antioxidants/therapeutic use , Lung/radiation effects , Metalloproteins/therapeutic use , Radiation Injuries, Experimental/prevention & control , Radiation Pneumonitis/prevention & control , Radiation-Protective Agents/therapeutic use , Superoxide Dismutase/therapeutic use , Animals , Antioxidants/administration & dosage , Antioxidants/pharmacology , Body Weight/drug effects , Body Weight/radiation effects , Cattle , Collagen/analysis , Female , Fibrosis , Injections, Subcutaneous , Lung/chemistry , Lung/drug effects , Lung/physiopathology , Macrophage Activation/drug effects , Macrophage Activation/radiation effects , Metalloproteins/administration & dosage , Metalloproteins/pharmacology , Radiation Pneumonitis/pathology , Radiation-Protective Agents/administration & dosage , Radiation-Protective Agents/pharmacology , Rats , Rats, Inbred F344 , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism , Respiratory Rate/drug effects , Respiratory Rate/radiation effects , Superoxide Dismutase/administration & dosage , Superoxide Dismutase/pharmacology
8.
J Biol Inorg Chem ; 19(6): 839-51, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24557708

ABSTRACT

Conversion of prion protein (PrP) to an altered conformer, the scrapie PrP (PrP(Sc)), is a critical step in the development of transmissible spongiform encephalopathies. Both Cu(II) and nucleic acid molecules have been implicated in this conversion. Full-length PrP can bind up to six copper ions; four Cu(II) binding sites are located in the octarepeat domain (residues 60-91), and His-96 and His-111 coordinate two additional copper ions. Experimental evidence shows that PrP binds different molecules, resulting in diverse cellular signaling events. However, there is little information about the interaction of macromolecular ligands with Cu(II)-bound PrP. Both RNA and DNA sequences can bind PrP, and this interaction results in reciprocal conformational changes. Here, we investigated the interaction of Cu(II) and nucleic acids with amyloidogenic non-octarepeat PrP peptide models (comprising human PrP residues 106-126 and hamster PrP residues 109-149) that retain His-111 as the copper-anchoring residue. The effect of Cu(II) and DNA or RNA sequences in the aggregation, conformation, and toxicity of PrP domains was investigated at low and neutral pH. Circular dichroism and EPR spectroscopy data indicate that interaction of the PrP peptides with Cu(II) and DNA occurs at pH 7. This dual interaction induces conformational changes in the peptides, modulating their aggregation, and affecting the morphology of the aggregated species, resulting in different cytotoxic effects. These results provide new insights into the role of Cu(II) and nucleic acid sequences in the structural conversion and aggregation of PrP, which are both critical events related to prion pathogenesis.


Subject(s)
Copper/chemistry , Metalloproteins/pharmacology , Nucleic Acids/chemistry , Peptides/chemistry , Prions/chemistry , Animals , Cell Survival/drug effects , Cells, Cultured , Cricetinae , Dose-Response Relationship, Drug , Humans , Hydrogen-Ion Concentration , Metalloproteins/chemistry , Mice , Structure-Activity Relationship
9.
Chemistry ; 19(39): 13017-29, 2013 Sep 23.
Article in English | MEDLINE | ID: mdl-23934861

ABSTRACT

The synthesis and stereochemical assignment of two classes of iron-containing nucleoside analogues, both of which contain a butadiene-Fe(CO)3 substructure, is described. The first type of compounds are Fe(CO)3-complexed 3'-alkenyl-2',3'-dideoxy-2',3'-dehydro nucleosides (2,5-dihydrofuran derivatives), from which the second class of compounds is derived by formal replacement of the ring oxygen atom by a CH2 group (carbocyclic nucleoside analogues). These compounds were prepared in a stereoselective manner through the metal-assisted introduction of the nucleobase. Whilst the furanoid intermediates were prepared from carbohydrates (such as methyl-glucopyranoside), the carbocyclic compounds were obtained by using an intramolecular Pauson-Khand reaction. Stereochemical assignments based on NMR and CD spectroscopy were confirmed by X-ray structural analysis. Biological investigations revealed that several of the complexes exhibited pronounced apoptosis-inducing properties (through an unusual caspase 3-independent but ROS-dependent pathway). Furthermore, some structure-activity relationships were identified, also as a precondition for the design and synthesis of fluorescent and biotin-labeled conjugates.


Subject(s)
Biotin/chemical synthesis , Fluorescent Dyes/chemical synthesis , Iron/chemistry , Metalloproteins/chemical synthesis , Metalloproteins/pharmacology , Nucleosides/chemical synthesis , Nucleosides/pharmacology , Apoptosis/drug effects , Biotin/chemistry , Fluorescent Dyes/chemistry , Magnetic Resonance Spectroscopy , Metalloproteins/chemistry , Molecular Structure , Nucleosides/chemistry , Structure-Activity Relationship , X-Ray Diffraction
10.
Metallomics ; 5(7): 793-803, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23775512

ABSTRACT

With the rapid development of engineered nanomaterials (NMs) and wide biomedical applications for new types of multifunctional NMs, an understanding of the behavior patterns of NMs in vivo and clarification of their potential health impact as a result of their novel physicochemical properties is essential for ensuring safety in biomedical applications of nanotechnology. NMs have heterogeneous characteristics in that they combine the bulk properties of solids with the mobility of molecules, and present phase transformation, dissolution, oxidation/reduction as well as nano-bio interface reactions in biological milieu, which affect their in vivo behaviors and biological effects. The accurate study of identification, quantification, transformation state of NMs and their biological effects in vivo remains a challenge. This review aims to provide a "metallomics" (an integrated metal-assisted function bioscience) insight into the in vivo behavior and biological effects of NMs, particularly for metal-based nanomaterials (MNMs) and is based mainly on our own research and other previous works.


Subject(s)
Metalloproteins/chemistry , Nanostructures , Proteomics , Animals , Humans , Metalloproteins/pharmacology , Oxidation-Reduction , Pharmacokinetics
11.
Toxicon ; 60(3): 302-11, 2012 Sep 01.
Article in English | MEDLINE | ID: mdl-22579637

ABSTRACT

As one of the major protein (enzyme) components of snake venom (SV), L-amino acid oxidase (LAAO) plays an important role in the toxicities and biological activities for SV. Accumulated researches in the past decade gradually revealed that SV-LAAOs induce platelet aggregation, cell apoptosis and cytotoxicity, and have anti-microbial, anti-leishmaniasis, anti-tumor and anti-HIV activity. Except for the enzymatic and structural characteristics of SV-LAAOs, the biological functions of SV-LAAOs and relevant action mechanisms are also summarized and discussed in the review. This work might provide useful inputs for future studies on SV-LAAOs.


Subject(s)
Drug Discovery , L-Amino Acid Oxidase/metabolism , Reptilian Proteins/metabolism , Snake Venoms/enzymology , Animals , Anti-Infective Agents/chemistry , Anti-Infective Agents/metabolism , Anti-Infective Agents/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Coagulants/chemistry , Coagulants/metabolism , Coagulants/pharmacology , Glycoproteins/chemistry , Glycoproteins/metabolism , Glycoproteins/pharmacology , Humans , L-Amino Acid Oxidase/chemistry , L-Amino Acid Oxidase/pharmacology , Metalloproteins/chemistry , Metalloproteins/metabolism , Metalloproteins/pharmacology , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/chemistry , Platelet Aggregation Inhibitors/metabolism , Platelet Aggregation Inhibitors/pharmacology , Protein Conformation , Reptilian Proteins/chemistry , Reptilian Proteins/pharmacology
12.
Curr Drug Metab ; 13(3): 306-20, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22455554

ABSTRACT

Metallomics and metalloproteomics are emerging fields addressing the role, uptake, transport and storage of trace metals ions both toxic and essential for an organism. Research areas related to the understanding of the mechanisms of life processes associated to metals are covered. Similarly to the genome and proteome terms, metallome was introduced to refer to metalloproteins, metalloenzymes and other metal-containing biomolecules in a biological system. This review aims to give an overview of metal ions behaviour in organisms. The interactions of metals with biomolecules such as amino acids, peptides and protein are the main focus. Special attention is paid to the application of nanotechnology-based techniques using these interactions for medical purposes such as diagnostics, imaging and therapy.


Subject(s)
Drug Delivery Systems , Metalloproteins/pharmacology , Metals/pharmacology , Amino Acids/metabolism , Animals , Biological Transport , Humans , Metalloproteins/administration & dosage , Metalloproteins/chemistry , Metals/administration & dosage , Metals/chemistry , Nanotechnology/methods , Proteins/metabolism
13.
Protein Pept Lett ; 19(2): 198-202, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21838699

ABSTRACT

Rare earth elements (REEs), which include 17 elements in the periodic table, share chemical properties related to a similar external electronic configuration. REEs enriched fertilizers have been used in China since the 1980s. REEs could enter the cell and cell organelles, influence plant growth, and mainly be bound with the biological macromolecules. REE-binding proteins have been found in some plants. In addition, the chlorophyll activities and photosynthetic rate can be regulated by REEs. REEs could promote the protective function of cell membrane and enhance the plant resistance capability to stress produced by environmental factors, and affect the plant physiological mechanism by regulating the Ca²âº level in the plant cells. The focus of present review is to describe how REEs and REE-binding proteins participate in the physiological responses in plants.


Subject(s)
Metalloproteins/pharmacology , Metals, Rare Earth/pharmacology , Plant Physiological Phenomena/drug effects , Antioxidants/metabolism , Calcium/metabolism , Carrier Proteins/metabolism , Carrier Proteins/pharmacology , Metalloproteins/metabolism , Metals, Rare Earth/metabolism , Models, Biological , Plant Development , Plants/drug effects , Plants/metabolism
14.
Clin Lymphoma Myeloma Leuk ; 11(6): 490-7, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21889435

ABSTRACT

INTRODUCTION: It was demonstrated that metallopanstimulin-1 (MPS-1, RPS27) inhibited the growth of tumors formed by head and neck squamous cell carcinoma cells and reduced paxillin gene expression. METHODS: The present study examined whether and how MPS-1 affects another type of cancer, multiple myeloma (CAG). Enhanced expression of MPS-1 dramatically inhibited CAG in vitro and in vivo. RESULTS: Overexpression of MPS-1 resulted in decreased fibroblast growth factor (FGF2) receptor 3 and impaired endogenous MAPK/ErK signaling. MAPK/ErK signaling was not stimulated by adding recombinant FGF2 to myeloma cells overexpressing MPS-1. CONCLUSIONS: These data suggest that MPS-1 suppresses CAG growth and that weakened FGF2 signaling may contribute to this effect.


Subject(s)
Metalloproteins/biosynthesis , Multiple Myeloma/metabolism , Nuclear Proteins/biosynthesis , RNA-Binding Proteins/biosynthesis , Receptor, Fibroblast Growth Factor, Type 3/antagonists & inhibitors , Ribosomal Proteins/biosynthesis , Animals , Apoptosis/physiology , Cell Growth Processes/physiology , Cell Line, Tumor , Culture Media, Conditioned , Fibroblast Growth Factors/metabolism , Gene Expression Profiling , Humans , MAP Kinase Signaling System , Male , Metalloproteins/genetics , Metalloproteins/pharmacology , Mice , Mice, Nude , Multiple Myeloma/genetics , Multiple Myeloma/pathology , Nuclear Proteins/genetics , Nuclear Proteins/pharmacology , RNA-Binding Proteins/genetics , RNA-Binding Proteins/pharmacology , Receptor, Fibroblast Growth Factor, Type 3/biosynthesis , Receptor, Fibroblast Growth Factor, Type 3/genetics , Ribosomal Proteins/genetics , Ribosomal Proteins/pharmacology , Signal Transduction , Transfection , Transplantation, Heterologous
15.
Protein Pept Lett ; 16(2): 116-20, 2009.
Article in English | MEDLINE | ID: mdl-19200033

ABSTRACT

Currently, no pharmaceuticals for the etiological treatment of neurodegenerative protein-misfolding diseases (e.g., ALS, Alzheimer's or prion diseases) are available. In this brief communication the development of chaperone-based medications from medicinal plants (e.g., Ginkgo biloba) are reviewed as referred to specific protein-protein interactions of plant metallochaperones and human enzymes. It is indicated that bioactive copper chaperones for superoxide dismutase isolated from medicinal plants may be lead molecules for drug development in several diseases concerning metal ion metabolisms of man and animals.


Subject(s)
Molecular Chaperones/chemistry , Nervous System Diseases/drug therapy , Plant Extracts/chemistry , Plant Proteins/chemistry , Plants, Medicinal/chemistry , Alzheimer Disease/drug therapy , Copper/metabolism , Drug Discovery , Ginkgo biloba/chemistry , Humans , Metalloproteins/chemistry , Metalloproteins/pharmacology , Molecular Chaperones/pharmacology , Nuclear Magnetic Resonance, Biomolecular , Phytotherapy , Plant Extracts/pharmacology , Plant Proteins/pharmacology , Protein Folding/drug effects , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Superoxide Dismutase/metabolism , Superoxide Dismutase-1
16.
Oral Microbiol Immunol ; 23(3): 213-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18402607

ABSTRACT

INTRODUCTION: Dental caries has been closely linked to fermentable carbohydrates as key environmental factors. Sucrose has been identified as the most cariogenic carbohydrate. Streptococcus mutans, considered to be the primary pathogen causing dental caries, is able to utilize sucrose as a nutrient source, partially for the production of intracellular storage components and for the production of extracellular glucans via the glucosyltransferases GtfB, GtfC, and GtfD. The following study explores the competitiveness and fitness of S. mutans when grown with different concentrations of sucrose. METHODS: Growth competition with oral streptococci and antimicrobial susceptibility in static biofilm models grown without sucrose or with 0.1% or 0.5% sucrose were investigated using confocal laser scanning microscopy. The numbers of surviving S. mutans of both wild-type and an isogenic Gtf-negative mutant after antimicrobial treatment were determined as colony-forming units. RESULTS: S. mutans was able to establish microcolonies with increasing sucrose concentration in the presence of other streptococcal competitors during biofilm development. The antimicrobial susceptibility decreased when sucrose was available as substrate and was dependent on the presence of the Gtfs. CONCLUSION: The increased resistance against antimicrobial treatment was associated with the availability of sucrose, but was not influenced much by the concentration used during this study. The resistance was strongly associated with the Gtf activity, excluding any intracellular metabolic effect of sucrose in the resistance mechanism.


Subject(s)
Cariogenic Agents/pharmacology , Streptococcus mutans/growth & development , Sucrose/pharmacology , Anti-Infective Agents, Local/administration & dosage , Anti-Infective Agents, Local/pharmacology , Biofilms/drug effects , Biofilms/growth & development , Cariogenic Agents/administration & dosage , Chlorhexidine/administration & dosage , Chlorhexidine/analogs & derivatives , Chlorhexidine/pharmacology , Colony Count, Microbial , Drug Combinations , Glucosyltransferases/genetics , Humans , Metalloproteins/administration & dosage , Metalloproteins/pharmacology , Microbial Sensitivity Tests , Microscopy, Confocal , Mouth/microbiology , Mutation/genetics , Salicylates/administration & dosage , Salicylates/pharmacology , Streptococcus gordonii/drug effects , Streptococcus gordonii/growth & development , Streptococcus mitis/drug effects , Streptococcus mitis/growth & development , Streptococcus mutans/drug effects , Streptococcus mutans/enzymology , Streptococcus oralis/drug effects , Streptococcus oralis/growth & development , Streptococcus sobrinus/drug effects , Streptococcus sobrinus/growth & development , Sucrose/administration & dosage , Terpenes/administration & dosage , Terpenes/pharmacology
17.
J Am Chem Soc ; 127(23): 8408-15, 2005 Jun 15.
Article in English | MEDLINE | ID: mdl-15941274

ABSTRACT

The reactivity of two [peptide-Cu] complexes ([GGH-Cu](-) and [KGHK-Cu](+)) toward DNA cleavage has been quantitatively investigated. Neither complex promoted hydrolytic cleavage, but efficient oxidative cleavage was observed in the presence of a mild reducing agent (ascorbate) and dioxygen. Studies with scavengers of ROS confirmed hydrogen peroxide to be an obligatory diffusible intermediate. While oxidative cleavage of DNA was observed for Cu(2+)(aq) under the conditions used, the kinetics of cleavage and reaction products/pathway were distinct from those displayed by [peptide-Cu] complexes. DNA cleavage chemistry is mediated by the H(2)O-dependent pathway following C-4'H abstraction from the minor groove. Such a cleavage path also provides a ready explanation for the linearization reaction promoted by [KGHK-Cu](+). Kinetic activities and reaction pathways are compared to published results on other chemical nucleases. Both [peptide-Cu] complexes were found to display second-order kinetics, with rate constants k(2) approximately 39 and 93 M(-1) s(-1) for [GGH-Cu](-) and [KGHK-Cu](+), respectively. Neither complex displayed enzyme-like saturation behavior, consistent with the relatively low binding affinity and residence time expected for association with dsDNA, and the absence of a prereaction complex. However, the intrinsic activity of each is superior to other catalyst systems, as determined from relative k(2) or k(cat)/K(m) values. Linearization of DNA was observed for [KGHK-Cu](+) relative to [GGH-Cu](-), consistent with the increased positive charge and longer residency time on dsDNA.


Subject(s)
Copper/chemistry , DNA/chemistry , Metalloproteins/chemistry , Oligopeptides/chemistry , Copper/pharmacology , DNA/drug effects , DNA/metabolism , DNA Damage , Drug Stability , Kinetics , Metalloproteins/pharmacology , Oligopeptides/pharmacology , Oxidation-Reduction
18.
J Pharm Pharmacol ; 57(2): 213-8, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15720785

ABSTRACT

The metalloantibiotic bacitracin is a known inhibitor of protein disulfide isomerase (PDI). The disulfide-linked interleukin-12 (IL-12) alphabeta-heterodimer and beta2-homodimer forms are crucial mediators of cell-mediated immune responses and inflammatory reactions. Bacitracin was found to potently block secretion of both the alphabeta- and beta2-dimer forms of IL-12, while it did not affect secretion of the beta-monomer. This inhibition coincided with a reduction in the intracellular amount of PDI found in complex with the beta-chain during intracellular transit. Bacitracin did not affect mRNA levels of the alphabeta- and beta-chain. Similar to bacitracin, N-acetylcysteine blocked alphabeta- and beta2-secretion as well as PDI-beta-chain complex formation. Thus, blocking PDI or shifting the endoplasmic reticulum towards a more reduced status disrupts the oxidative folding pathway or assembly of IL-12 dimer forms. The assembly stage of cytokines in the endoplasmic reticulum may represent a novel target for pharmacological intervention.


Subject(s)
Bacitracin/pharmacology , Interleukin-12/antagonists & inhibitors , Interleukin-12/metabolism , Acetylcysteine/pharmacology , Animals , Bacitracin/chemistry , Cell Line , Drug Evaluation, Preclinical/methods , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/enzymology , Humans , Interleukin-12/genetics , Metalloproteins/chemistry , Metalloproteins/pharmacology , Protein Disulfide-Isomerases/antagonists & inhibitors , Protein Disulfide-Isomerases/physiology , RNA, Messenger , Reverse Transcriptase Polymerase Chain Reaction
19.
Kidney Int ; 64(6): 1968-77, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14633119

ABSTRACT

BACKGROUND: The ureteric buds and metanephric mesenchymal cells reciprocally induce each other's maturation during kidney development, and implicated transcription factors, secreted growth factors, and cell surface signaling peptides are critical regulators of renal branching morphogenesis. Protein kinase C (PKC) is a key enzyme in the signal transduction mechanisms in various biologic processes, including development, because it regulates growth and differentiation. Inhibition of PKC by the sphingolipid product ceramide interferes with nephron formation in the developing kidney, but the molecule that controls ureteric bud branching downstream of PKC is still unknown. METHODS: Differential display polymerase chain reaction (PCR) of metanephroi cultured with a PKC activator and inhibitor was performed. We also examined the role of a novel gene in kidney development with organ culture system. RESULTS: A novel gene encoding a 759 bp mRNA was identified, and we named it metanephros-derived tubulogenic factor (MTF)/L47. Inhibition of MTF with antisense oligonucleotide impaired ureteric bud branching by cultured metanephroi, and addition of recombinant MTF protein promoted ureteric bud branching in cultured metanephroi and increased cell proliferation. CONCLUSION: We identified a novel molecule in developing kidney that is capable of modulating ureteric bud branching and kidney differentiation.


Subject(s)
Gene Expression Regulation, Developmental , Kidney/embryology , Membrane Proteins/genetics , Metalloproteins/genetics , Neoplasm Proteins/genetics , Ribosomal Proteins/genetics , Ureter/embryology , Aging/genetics , Aging/metabolism , Amino Acid Sequence , Animals , Apoptosis , Cell Division/drug effects , Cloning, Molecular , Embryo, Mammalian/cytology , Embryo, Mammalian/drug effects , Embryo, Mammalian/physiology , Embryonic and Fetal Development/genetics , Enzyme Activation/physiology , GPI-Linked Proteins , Kidney/growth & development , Kidney/metabolism , Membrane Proteins/metabolism , Membrane Proteins/pharmacology , Membrane Proteins/physiology , Metalloproteins/metabolism , Metalloproteins/pharmacology , Metalloproteins/physiology , Mice , Mice, Inbred ICR , Molecular Sequence Data , Neoplasm Proteins/metabolism , Neoplasm Proteins/pharmacology , Neoplasm Proteins/physiology , Organ Culture Techniques , Protein Kinase C/metabolism , RNA, Messenger/metabolism , Recombinant Proteins/pharmacology , Ribosomal Proteins/metabolism , Ribosomal Proteins/pharmacology , Ribosomal Proteins/physiology , Tissue Distribution
20.
J Biochem ; 131(2): 233-9, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11820937

ABSTRACT

The apoptotic cell death of Jurkat cells due to Cd(2+) toxicity was studied by fluorescence microscopic observation and DNA fragmentation assaying. It was suggested that the apoptotic response to Cd(2+) was less clear than that to a typical apoptosis inducer, ultraviolet light (254 nm). Examination of MAP kinase phosphorylation (p38, JNKs, and c-Jun) due to Cd(2+) toxicity indicated that the phosphorylation was very slowly activated (4 h after stimulation), while UV light could activate the phosphorylation immediately. Therefore, it was suggested that Cd(2+) may not be a typical apoptosis inducer. Antioxidants [glutathione (GSH) and N-acetylcysteine (NAC)] could detoxify Cd(2+), indicating that the toxicity is a kind of oxidative stress. The detoxification effect of antioxidants showed cooperation with Bcl-2, suggesting that Cd(2+)-treatment causes diversified toxic signals including oxidative stress. On the addition of a plant-specific peptide, phytochelatin [PC(7), (gammaGlu-Cys)(7)-Gly], to the medium, the detoxification of Cd(2+) and cooperation with Bcl-2 were more intense than in the cases of GSH and NAC. Using an appropriate vector, a PC synthase gene was transferred from Arabidopsis thaliana to the Jurkat cell. The transfectant exhibited resistance to Cd(2+) and production of plant-specific PC (PC(2-6)).


Subject(s)
Apoptosis/drug effects , Cadmium/toxicity , Chelating Agents/pharmacology , Jurkat Cells/drug effects , Metalloproteins/pharmacology , Acetylcysteine/metabolism , Aminoacyltransferases/genetics , Aminoacyltransferases/metabolism , Aminoacyltransferases/pharmacology , Blotting, Western , Cell Nucleus/metabolism , Cells, Cultured/drug effects , Cells, Cultured/metabolism , Chelating Agents/metabolism , DNA Primers/chemistry , Drug Resistance , Free Radical Scavengers/metabolism , Glutathione/metabolism , Humans , Inactivation, Metabolic , JNK Mitogen-Activated Protein Kinases , MAP Kinase Kinase 4 , Metalloproteins/metabolism , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/metabolism , Oxidative Stress , Phytochelatins , Plants/chemistry , Plasmids , Polymerase Chain Reaction , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Time Factors , Transfection , p38 Mitogen-Activated Protein Kinases
SELECTION OF CITATIONS
SEARCH DETAIL
...